Drawing for Serial No. 79461682

USPTO serial 79461682

Serial No. 79461682

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with Serial No. 79461682?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; therapeutic and prophylactic preparations for the treatment, prevention or management of blood clots, thrombosis, coagulation disorders and cardiovascular condition; anti-fibrinolytic pharmaceutical preparations; small molecule anti fibrinolytic agents for medical use; biopharmaceutical preparations; medicinal preparations containing biological materials; anti thrombotic agents; anticoagulant and antiplatelet preparations; diagnostic preparations for medical purposes; drug delivery agents comprising compounds that facilitate delivery of pharmaceutical preparations; medical and veterinary preparations; dietetic preparations and substances for medical use.ACTIVE—
042Medical and pharmaceutical research and development; scientific and technological services in the field of thrombosis, coagulation disorders, cardiovascular health and therapeutic development; medical and pharmaceutical research and development; laboratory research services; clinical research; design and development of medical diagnostic tests, therapeutic platforms and drug delivery systems; biotechnology research; providing scientific information and consultancy relating to pharmaceuticals and therapeutics.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 4, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 29, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance